Insider Transactions in Q2 2022 at Medicine Man Technologies, Inc. (SHWZ)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2022
|
Jonathan W Berger Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,085
+17.94%
|
-
|
|
Jun 24
2022
|
Salim Husan Wahdan Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,170
+35.56%
|
-
|
|
Jun 14
2022
|
Jonathan W Berger Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,728
+25.0%
|
-
|
|
Jun 14
2022
|
Jeffrey Alley Cozad Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,728
+20.58%
|
-
|
|
Jun 14
2022
|
Jeff Garwood Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,728
+8.16%
|
-
|
|
Jun 14
2022
|
Paul Joseph Montalbano Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,728
+19.45%
|
-
|
|
Jun 14
2022
|
Pratap Chandra Mukharji Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,728
+20.58%
|
-
|
|
Jun 14
2022
|
Brian Ruden > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
22,728
+20.96%
|
-
|
|
May 04
2022
|
Jonathan W Berger Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,463
+47.09%
|
-
|
|
May 04
2022
|
Jeffrey Alley Cozad Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,463
+38.38%
|
-
|
|
May 04
2022
|
Jeff Garwood Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,463
+14.79%
|
-
|
|
May 04
2022
|
Paul Joseph Montalbano Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,463
+36.18%
|
-
|
|
May 04
2022
|
Pratap Chandra Mukharji Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,463
+38.38%
|
-
|
|
May 04
2022
|
Brian Ruden > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
20,232
+24.32%
|
-
|
|
Apr 19
2022
|
Jeff Garwood Director |
BUY
Open market or private purchase
|
Direct |
19,304
+9.1%
|
$19,304
$1.82 P/Share
|
|
Apr 18
2022
|
Jeff Garwood Director |
BUY
Open market or private purchase
|
Direct |
12,696
+6.82%
|
$12,696
$1.97 P/Share
|
|
Apr 13
2022
|
Jeff Garwood Director |
BUY
Open market or private purchase
|
Direct |
8,000
+4.74%
|
$16,000
$2.06 P/Share
|
|
Apr 12
2022
|
Jeff Garwood Director |
BUY
Open market or private purchase
|
Direct |
10,000
+6.15%
|
$20,000
$2.1 P/Share
|
|
Apr 11
2022
|
Jeff Garwood Director |
BUY
Open market or private purchase
|
Direct |
15,000
+9.51%
|
$30,000
$2.11 P/Share
|
|
Apr 08
2022
|
Jeff Garwood Director |
BUY
Open market or private purchase
|
Direct |
13,500
+9.56%
|
$27,000
$2.05 P/Share
|
|
Apr 07
2022
|
Jeff Garwood Director |
BUY
Open market or private purchase
|
Direct |
1,500
+1.3%
|
$3,000
$2.04 P/Share
|
|
Apr 07
2022
|
Justin Dye Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.67%
|
$2,000
$2.03 P/Share
|
|
Apr 06
2022
|
Jeff Garwood Director |
BUY
Open market or private purchase
|
Direct |
5,000
+4.25%
|
$10,000
$2.08 P/Share
|
|
Apr 06
2022
|
Justin Dye Director |
BUY
Grant, award, or other acquisition
|
Direct |
67,355
+31.32%
|
$134,710
$2.05 P/Share
|